Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,289 | 12,608 | 12,103 | 24,351 | 21,295 |
| Marketable Securities | N/A | N/A | N/A | N/A | 326 |
| Receivables | 12 | 127 | 426 | 4,922 | 843 |
| Other current assets | 0 | 0 | 0 | 1,060 | 645 |
| TOTAL | $15,041 | $13,194 | $13,327 | $30,333 | $23,109 |
| Non-Current Assets | |||||
| PPE Net | 3 | 2 | 3 | 4 | 6 |
| Investments And Advances | 0 | 0 | 0 | 86 | 89 |
| Intangibles | 13,443 | 14,158 | 14,825 | 16,474 | 16,697 |
| Other Non-Current Assets | 103 | 296 | 409 | 486 | 645 |
| TOTAL | $13,549 | $14,455 | $15,236 | $17,049 | $17,437 |
| Total Assets | $28,590 | $27,649 | $28,563 | $47,383 | $40,546 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,154 | 2,244 | 1,439 | 2,021 | 1,356 |
| Accrued Expenses | 2,950 | 1,463 | 1,186 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 297 | 278 |
| TOTAL | $4,221 | $3,829 | $2,739 | $2,435 | $1,764 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,871 | 5,366 | 2,711 | 1,966 | 1,322 |
| TOTAL | $5,366 | $6,330 | $3,814 | $3,658 | $3,217 |
| Total Liabilities | $9,587 | $10,159 | $6,552 | $6,092 | $4,981 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,358 | N/A | N/A | N/A | N/A |
| Common Shares | 0 | 0 | N/A | 157,938 | 142,110 |
| Retained earnings | -178,347 | -177,977 | -162,485 | -125,734 | -115,099 |
| Other shareholders' equity | -2,845 | -3,014 | -3,059 | 9,086 | 8,554 |
| TOTAL | $19,003 | $17,490 | $22,011 | $41,290 | $35,565 |
| Total Liabilities And Equity | $28,590 | $27,649 | $28,563 | $47,383 | $40,546 |